Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,497 INR | +2.30% | +3.33% | +20.11% |
Mar. 27 | Cipla Gets Regulatory Nod to Merge US-Based Subsidiaries | MT |
Mar. 27 | Cipla to Distribute Sanofi's CNS Product Line in India | MT |
Sales 2024 * | 258B 3.1B | Sales 2025 * | 280B 3.37B | Capitalization | 1,209B 14.5B |
---|---|---|---|---|---|
Net income 2024 * | 41.44B 497M | Net income 2025 * | 45.06B 541M | EV / Sales 2024 * | 4.45 x |
Net cash position 2024 * | 58.72B 705M | Net cash position 2025 * | 83.96B 1.01B | EV / Sales 2025 * | 4.01 x |
P/E ratio 2024 * |
29.4
x | P/E ratio 2025 * |
26.8
x | Employees | 32,323 |
Yield 2024 * |
0.57% | Yield 2025 * |
0.61% | Free-Float | 64.49% |
Latest transcript on Cipla Limited
1 day | +2.30% | ||
1 week | +3.33% | ||
Current month | +1.12% | ||
1 month | +1.35% | ||
3 months | +18.73% | ||
6 months | +28.60% | ||
Current year | +20.11% |
Managers | Title | Age | Since |
---|---|---|---|
Umang Vohra
CEO | Chief Executive Officer | 52 | 15-09-30 |
Ashish Adukia
DFI | Director of Finance/CFO | - | 22-08-15 |
Geena Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 85-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ashok K. Sinha
BRD | Director/Board Member | 72 | 13-07-15 |
Chairman | 87 | 72-07-20 | |
Director/Board Member | 83 | 77-08-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.99% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1,497 | +2.30% | 2,110,407 |
24-03-27 | 1,463 | -0.60% | 1,642,266 |
24-03-26 | 1,472 | -0.61% | 1,635,695 |
24-03-22 | 1,481 | +2.25% | 1,746,930 |
24-03-21 | 1,449 | +2.21% | 1,699,939 |
Delayed Quote NSE India S.E., March 28, 2024 at 08:01 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.11% | 14.49B | |
+28.67% | 46.63B | |
+19.30% | 22.49B | |
+0.55% | 12.98B | |
+46.16% | 12.16B | |
-2.44% | 7.69B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.80% | 5.15B | |
+5.83% | 4.64B |